https://www.ndtvprofit.com/coronavirus-outbreak/russia-s-sputnik-v-vaccine-gets-nod-for-emergency-use-in-india?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
The vaccine has shown 91.6% efficacy in interim analysis of phase 3 clinical trials.